NSEGeneral UpdatesFundraise19h ago
Anupam Rasayan India Limited
General Updates
Anupam Rasayan India Limited has informed the Exchange about Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders, by the Company together with PAC.
NSECopy of Newspaper PublicationM&A3d ago
Anupam Rasayan India Limited
Copy of Newspaper Publication
Anupam Rasayan India Limited has submitted a copy of a newspaper publication regarding an addendum to the public announcement, detailed public statement, and draft letter of offer for the acquisition of a 26% stake in Bliss GVS Pharma Limited.
NSEGeneral UpdatesM&A4d ago
Anupam Rasayan India Limited
General Updates
Anupam Rasayan India Limited has acquired 100% of Mates Visa Consultancy Private Limited, an unlisted private company providing visa and passport consultancy services, for INR 10,000.
NSEPress Release▲ PositiveOrder Win15 Jul 2026
Anupam Rasayan India Limited
Press Release
Anupam Rasayan India Limited has signed a non-binding Letter of Intent (LOI) with BASQUEVOLT, S.A. to explore the potential supply of a specialty chemical product worth $300 Mn over a period of up to 10 years.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026
Anupam Rasayan India Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Anupam Rasayan India Limited has received a confirmation certificate from MUFG Intime India Private Limited stating that Regulation 74(5) of SEBI (DP) Regulations, 2018 is not applicable to the company as all its shares are in dematerialized form and no requests for rematerialization were received during the quarter ended June 30, 2026.
NSETrading WindowResults25 Jun 2026
Anupam Rasayan India Limited
Trading Window
Anupam Rasayan India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from July 1, 2026, till the end of 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026.